%20(2).png)
EGFR/HER2 Vaccine – Compassionate Access​
The EGFR/HER2 peptide vaccine (Yale/Therajan) is an investigational immunotherapy that may be available for dogs who have limited treatment options. This program allows eligible dogs to receive the vaccine outside of a clinical trial, under veterinary and regulatory oversight.
Who may qualify?
-
Dogs with a confirmed cancer diagnosis, limited standard options, and a veterinary oncologist willing to coordinate records may be considered. Final eligibility is determined by the Yale/Therajan team.
How to request access
-
Your veterinary oncologist must send a brief summary letter and medical records to Professor Mamula’s team, copying Canine Cancer Alliance.
-
Once the letter is received, we will email you the full instructions and next steps.
-
CCA Email: info@ccralliance.org
Betty Boop, a 2-year hemangiosarcoma survivor. 🩷
In April 2023, Betty Boop was diagnosed with stage I splenic hemangiosarcoma. After splenectomy, her mom drove 5 hours to get Betty enrolled in the EGFR/HER2 vaccine immunotherapy trial. She didn’t get chemotherapy. Two years later, Betty is still going strong.
Every pup deserves a happy, healthy life.
.png)
100% of your gift funds research for prevention and cures
We are on a mission to prevent and cure cancer in over 20 million dogs affected each year.
You can join us. No matter how much you give, every dollar funds research to help animals.
Life-saving research for prevention and cures
To Donate with a Check
Please write a check out to Canine Cancer Alliance and mail it to:
Canine Cancer Alliance
P.O. Box 385
Bellevue, WA 98009
​​
Kindly fill out this form and include it with your check donation.
​
Your donation is tax-deductible.
The Federal Tax ID number is 82-3762441.